Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticotropin-releasing hormone receptors (CRHRs) are integral membrane proteins that mediate the effects of corticotropin-releasing hormone (CRH), a key neuropeptide involved in the stress response. There are two main subtypes: CRHR1 and CRHR2. Both belong to the G protein-coupled receptor (GPCR) superfamily and play central roles in regulating the hypothalamic-pituitary-adrenal (HPA) axis, which governs endocrine, behavioral, autonomic, and immune responses to stress.
Ligand binding induces conformational change in the receptor. Typically couples with Gαs proteins → activates adenylyl cyclase → increases cyclic AMP (cAMP). cAMP activates protein kinase A (PKA), leading to phosphorylation events that alter gene expression, hormonal secretion, metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-Releasing Hormone Receptor (CRHR).